These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Bimatoprost and its free acid are prostaglandin FP receptor agonists. Sharif NA, Williams GW, Kelly CR. Eur J Pharmacol; 2001 Dec 07; 432(2-3):211-3. PubMed ID: 11740958 [Abstract] [Full Text] [Related]
9. Human ciliary muscle cell responses to FP-class prostaglandin analogs: phosphoinositide hydrolysis, intracellular Ca2+ mobilization and MAP kinase activation. Sharif NA, Crider JY, Husain S, Kaddour-Djebbar I, Ansari HR, Abdel-Latif AA. J Ocul Pharmacol Ther; 2003 Oct 07; 19(5):437-55. PubMed ID: 14583136 [Abstract] [Full Text] [Related]
10. Evidence for the involvement of cannabinoid CB1 receptors in the bimatoprost-induced contractions on the human isolated ciliary muscle. Romano MR, Lograno MD. Invest Ophthalmol Vis Sci; 2007 Aug 07; 48(8):3677-82. PubMed ID: 17652738 [Abstract] [Full Text] [Related]
11. AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor. Griffin BW, Klimko P, Crider JY, Sharif NA. J Pharmacol Exp Ther; 1999 Sep 07; 290(3):1278-84. PubMed ID: 10454504 [Abstract] [Full Text] [Related]
13. The hydrolysis of the prostaglandin analog prodrug bimatoprost to 17-phenyl-trinor PGF2alpha by human and rabbit ocular tissue. Hellberg MR, Ke TL, Haggard K, Klimko PG, Dean TR, Graff G. J Ocul Pharmacol Ther; 2003 Apr 07; 19(2):97-103. PubMed ID: 12804054 [Abstract] [Full Text] [Related]
14. Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024). Woodward DF, Krauss AH, Chen J, Liang Y, Li C, Protzman CE, Bogardus A, Chen R, Kedzie KM, Krauss HA, Gil DW, Kharlamb A, Wheeler LA, Babusis D, Welty D, Tang-Liu DD, Cherukury M, Andrews SW, Burk RM, Garst ME. J Pharmacol Exp Ther; 2003 May 07; 305(2):772-85. PubMed ID: 12606640 [Abstract] [Full Text] [Related]
15. Aqueous humor concentrations of bimatoprost free acid, bimatoprost and travoprost free acid in cataract surgical patients administered multiple topical ocular doses of LUMIGAN or TRAVATAN. Faulkner R, Sharif NA, Orr S, Sall K, Dubiner H, Whitson JT, Moster M, Craven ER, Curtis M, Pailliotet C, Martens K, Dahlin D. J Ocul Pharmacol Ther; 2010 Apr 07; 26(2):147-56. PubMed ID: 20307216 [Abstract] [Full Text] [Related]
16. Studies using isolated uterine and other preparations show bimatoprost and prostanoid FP agonists have different activity profiles. Chen J, Senior J, Marshall K, Abbas F, Dinh H, Dinh T, Wheeler L, Woodward D. Br J Pharmacol; 2005 Feb 07; 144(4):493-501. PubMed ID: 15678094 [Abstract] [Full Text] [Related]
17. Prostaglandin subtype-selective and non-selective IOP-lowering comparison in monkeys. Gabelt BT, Hennes EA, Bendel MA, Constant CE, Okka M, Kaufman PL. J Ocul Pharmacol Ther; 2009 Feb 07; 25(1):1-8. PubMed ID: 19232013 [Abstract] [Full Text] [Related]
18. Expression and functional evidence of the prostaglandin F2alpha receptor mediating contraction in human umbilical vein. Errasti AE, del-Rey G, Cesio CE, Souza G, Nowak W, Pelorosso FG, Daray FM, Rothlin RP. Eur J Pharmacol; 2009 May 21; 610(1-3):68-74. PubMed ID: 19289115 [Abstract] [Full Text] [Related]
19. Bimatoprost and prostaglandin F(2 alpha) selectively stimulate intracellular calcium signaling in different cat iris sphincter cells. Spada CS, Krauss AH, Woodward DF, Chen J, Protzman CE, Nieves AL, Wheeler LA, Scott DF, Sachs G. Exp Eye Res; 2005 Jan 21; 80(1):135-45. PubMed ID: 15652534 [Abstract] [Full Text] [Related]
20. Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes. Liang Y, Woodward DF, Guzman VM, Li C, Scott DF, Wang JW, Wheeler LA, Garst ME, Landsverk K, Sachs G, Krauss AH, Cornell C, Martos J, Pettit S, Fliri H. Br J Pharmacol; 2008 Jul 21; 154(5):1079-93. PubMed ID: 18587449 [Abstract] [Full Text] [Related] Page: [Next] [New Search]